Gross Margin: A company's total sales revenue minus its cost of goods sold, divided by the total sales revenue, expressed as a percentage. Calculated as: Gross Income / Total Revenues
Insight Molecular Diagnostics Inc. (IMDX) had Gross Margin of 42.49% for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$1.14M |
|
$-22.95M |
|
$0.66M |
|
$0.48M |
|
$24.57M |
|
$-23.43M |
|
$0.48M |
|
$-22.95M |
|
$-22.95M |
|
$-22.95M |
|
$-22.95M |
|
$-22.95M |
|
$-22.95M |
|
$-23.43M |
|
$-22.87M |
|
30.48M |
|
30.48M |
|
$-0.75 |
|
$-0.75 |
|
| Balance Sheet Financials | |
$15.31M |
|
$6.43M |
|
$10.45M |
|
$25.76M |
|
$12.07M |
|
$45.15M |
|
$45.15M |
|
$57.22M |
|
$-31.46M |
|
$-31.46M |
|
$-31.46M |
|
28.68M |
|
| Cash Flow Statement Financials | |
$-22.18M |
|
$-3.19M |
|
$28.07M |
|
$10.34M |
|
$12.92M |
|
$2.58M |
|
$2.22M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.27 |
|
-- |
|
-- |
|
3.30 |
|
-1.43 |
|
|
Gross Margin |
42.49% |
-2057.51% |
|
-2057.51% |
|
-- |
|
-2015.37% |
|
-2015.37% |
|
$-25.37M |
|
-- |
|
-- |
|
-- |
|
0.04 |
|
1.47 |
|
1.01 |
|
89.13 |
|
72.96% |
|
72.96% |
|
-89.12% |
|
-167.79% |
|
$-1.10 |
|
$-0.83 |
|
$-0.73 |
|